European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Doctoral training network TAu imMunE: strategies for innovative diagnosis and therapies in dementia

Descripción del proyecto

Avanzar en la investigación del Alzheimer para un futuro más saludable

La enfermedad de Alzheimer y sus homólogas relacionadas con la proteína τ (tauopatías) engloban un espectro de trastornos neurodegenerativos caracterizados por la acumulación de proteína τ anormal en el encéfalo. Las tauopatías incluyen enfermedades como la parálisis supranuclear progresiva, la degeneración corticobasal y la demencia frontotemporal, entre otras. La necesidad acuciante de diagnósticos y tratamientos eficaces es innegable, dada la inmensa carga que estas enfermedades suponen para las personas, las familias y la sociedad en general. En este contexto, el proyecto TAME, financiado por las acciones Marie Skłodowska-Curie, reúne a destacados expertos del mundo universitario y del sector industrial a fin de mejorar la comprensión de las tauopatías y desarrollar diagnósticos e intervenciones personalizados más seguros. En concreto, el enfoque multidisciplinar del proyecto combina conocimientos de neurociencia molecular, informática, química y bioingeniería. Mediante la formación de nueve biólogos brillantes, el proyecto hace hincapié en la investigación, el desarrollo profesional y la ciencia abierta.

Objetivo

There is an urgent medical need for efficient diagnostics for Alzheimer’s disease and related tauopathies, as well as disease modifying treatments, due to the heavy burden of the disease on patients, families and society. To address this public health issue, TAME R&I training network gathers leading academic and industrial experts in tau research with the ambition to keep older people active and independent for longer. TAME aims to provide better understanding of tau-related diseases and supports the development of new, safer, personalised and more effective diagnosis and interventions for AD and the less common tauopathies. The beneficiaries and partners bring together resources and knowledge across different fields and technologies to provide a multidisciplinary approach necessary to take on the challenge. They have teamed-up to combine molecular and cellular neuroscience with computing, chemical and bio-engineering and their technology expertise. The first tau network of Europe, TAME, will focus on novel approaches using nanobodies, which have emerged as very promising antibody formats in tau research. The primary objective of the TAME is to train 9 fellows to deliver the next generation of talented life scientists. The program will be a combination of training in research, in personal and professional development and in open science, achieved by conducting research projects, attending courses and benefiting from internal mobility within TAME. The research training is based on cutting-edge technologies and advanced models for medical research, emphasizing the need for more human-based research, gender-personalised models and reduction in the use of animals. Consequently, through intense collaboration with all partners and the relevant industrial experience, these 9 fellows can anticipate improved career prospects and higher employability. TAME will provide an innovation-friendly framework in which scientific results can mature and be developed into products.

Coordinador

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Aportación neta de la UEn
€ 282 693,60
Dirección
RUE MICHEL ANGE 3
75794 Paris
Francia

Ver en el mapa

Región
Ile-de-France Ile-de-France Paris
Tipo de actividad
Research Organisations
Enlaces
Coste total
Sin datos

Participantes (8)

Socios (13)